Literature DB >> 15655439

PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.

Zhi-Liang Wang1, Xi Zhang, Xun Xu, Xiao-Dong Sun, Fang Wang.   

Abstract

PURPOSE: To study whether intravitreal injection of plasmin + hyaluronidase safely induces posterior vitreous detachment (PVD).
METHODS: Rabbits were randomized into three groups: (A) 20 rabbits, intravitreal injection of plasmin 1 U + hyaluronidase 20 U in balanced salt solution (BSS) 0.1 mL into one eye; (B) 12 rabbits, plasmin alone; (C) 12 rabbits, hyaluronidase alone. The fellow eye of each rabbit was injected BSS 0.1 mL. In Group A, scanning electron microscopy (SEM) was done in four rabbits at 0.5 hour and in four rabbits at 1 hour. After 7 days, all the remaining 36 rabbits received electroretinography, SEM was examined in eight of each group, and immunohistochemistry was done in four of each group.
RESULTS: SEM disclosed the eyes of Group A had complete PVD (8/8), Group B partial PVD (7/8), and Group C (8/8) and all the control eyes (24/24) no PVD after 7 days. Partial PVD was found in 4/4 at 0.5 hour and complete PVD was seen in 3/4 at 1 hour in Group A. Immunohistochemistry showed that the amounts of laminin and fibronectin in the vitreoretinal interface were decreased in Group A and B versus the control eyes (P <0.001), but not in Group C versus the control eyes (P >0.05). Electroretinography showed no changes in any group (P >0.05).
CONCLUSION: Vitreous injection of plasmin + hyaluronidase induced complete PVD with no obvious toxicity. Plasmin induced partial PVD, but hyaluronidase had no effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655439     DOI: 10.1097/00006982-200501000-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  9 in total

1.  Molecular biology of pharmacologic vitreolysis.

Authors:  J Sebag
Journal:  Trans Am Ophthalmol Soc       Date:  2005

2.  Safety profile of the intravitreal streptokinase-plasmin complex as an adjunct to vitrectomy in the rabbit.

Authors:  M Hermel; M Mahgoub; T Youssef; M I Azrak; H Raza; C Alldredge; M Trese; G A Williams; M Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-20       Impact factor: 3.117

3.  Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.

Authors:  Martin Hermel; Norbert F Schrage
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

4.  Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.

Authors:  Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

5.  Minimally invasive vitreoretinal surgery: is sutureless vitrectomy the future of vitreoretinal surgery?

Authors:  J Fernando Arevalo; María H Berrocal; Juan D Arias; Touka Banaee
Journal:  J Ophthalmic Vis Res       Date:  2011-04

6.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

7.  Pharmacologic vitreolysis.

Authors:  Hossein Nazari; Mehdi Modarres-Zadeh; Arash Maleki
Journal:  J Ophthalmic Vis Res       Date:  2010-01

Review 8.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17

Review 9.  Vitreous Antioxidants, Degeneration, and Vitreo-Retinopathy: Exploring the Links.

Authors:  Emmanuel Ankamah; J Sebag; Eugene Ng; John M Nolan
Journal:  Antioxidants (Basel)       Date:  2019-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.